Rose Pharma is focused on the development of novel treatments for IBS and anorexia/cachexia associated with cancer and other major pathologies. Rose’s lead molecule is an NCE analogue of GLP-1 in Phase II development.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.